NCT06496711 IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients
| NCT ID | NCT06496711 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cologne |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 600 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 600 participants in total. It began in 2023-09-01 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
IMPLEMENT aims to develop, test and establish a sustainable access structure for quality-assured oncological exercise therapy (qOET) in Germany as a model within the funding period of three years. This will be done in three phases: Phase 1: In the first step, a characterization of the existing implementation structures and the existing barriers and needs as well as the establishment of the cooperation with the most important actors in the care system will take place. Phase 2: In the subsequent implementation process, concrete measures are practically implemented in subprojects for specific target groups (children/adolescents, adults) and specific regions (rural, urban) as well as the digital solutions and interface management. With the help of a mixed-methods design, the barriers and facilitating factors of the implementation of area-wide qSBT will be investigated during the project and fed into a "learning system" for adaptation and improvement. Phase 3: The success of the measures to increase patient participation in qOET and the development of the structures as well as the barrier and facilitating factors for an effective implementation will be addressed in a before-after comparison through evaluation steps and an economic accompanying evaluation will be carried out.
Eligibility Criteria
Inclusion Criteria: * Patients with cancer * Healthcare providers (e.g. Medical Doctors, physiotherapists, nurses, psychologists) involved in the treatment and/or counseling of cancer patients, including aftercare. Exclusion Criteria (Cancer Patients): * Psychological and/or physical limitations that do not allow participation in quality-assured sports and exercise therapy (e.g. unstable cardiac arrhythmias)
Contact & Investigator
Freerk Baumann, Prof. Dr.
PRINCIPAL INVESTIGATOR
University of Cologne
Frequently Asked Questions
Who can join the NCT06496711 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06496711 currently recruiting?
Yes, NCT06496711 is actively recruiting participants. Contact the research team at freerk.baumann@uk-koeln.de for enrollment information.
Where is the NCT06496711 trial being conducted?
This trial is being conducted at Cologne, Germany.
Who is sponsoring the NCT06496711 clinical trial?
NCT06496711 is sponsored by University of Cologne. The principal investigator is Freerk Baumann, Prof. Dr. at University of Cologne. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.